NCT00751361View on ClinicalTrials.gov

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Dry Age Related Macular Degeneration
Interventions
DEVICE

Rheopheresis / double filtration plasmapheresis

Rheopheresis is a specific method of therapeutic apheresis, using the methodology of double filtration plasmapheresis.

Trial Locations (1)

60590

University of Frankfurt Department of Ophthalmology, Frankfurt

Sponsors
All Listed Sponsors
lead

Apheresis Research Institute

OTHER